Navigation Links
BCBSGA Announces Decision to Cover H1N1 Vaccine Administration
Date:8/3/2009

ATLANTA, Aug. 3 /PRNewswire/ -- Blue Cross and Blue Shield of Georgia (BCBSGA) announced today that it will offer coverage for the administration of the H1N1 (swine flu) vaccine when it becomes commercially available to the general public. The vaccine administration will be covered for members whose benefit plans provide coverage for vaccines.

BCBSGA will also continue coverage of seasonal flu vaccine administration for those whose health plans offer vaccine coverage. The U.S. Centers for Disease Control and Prevention has stated that the H1N1 vaccine is not intended to replace the seasonal flu vaccine. Seasonal flu and H1N1 vaccines may be administered on the same day, according to the CDC.

The decision to cover the H1N1 vaccine administration is based on formal recommendations announced this week by the CDC's Advisory Committee on Immunization Practices. ACIP recommended initial prioritization for those administering the vaccine for five key populations, including:

  • pregnant women,
  • people who live with or care for children younger than six months of age,
  • health care and emergency services personnel,
  • children and young adults from 6 months old to 24 years old, and
  • people from 25 through 64 years old if they have chronic medical conditions that increase their risk of complications from influenza infection.

ACIP also provided guidance regarding high risk groups to be targeted in the event of a significant shortage of vaccine as well as recommendations for the rest of the general population if the supply of vaccine exceeds the needs of the target groups.

BCBSGA's immunization policy decisions are based on recommendations issued by ACIP and other nationally recognized organizations. ACIP is composed of 15 experts in fields associated with immunization who provide advice and guidance to the U.S. Department of Health and Human Services and CDC on the most effective means to prevent vaccine-preventable diseases.

Vaccine administration is covered for members whose benefit plans provide coverage for vaccines. Policyholders should confirm their specific benefits by calling the toll-free telephone number listed on their insurance card.

About Blue Cross and Blue Shield of Georgia:

Blue Cross and Blue Shield of Georgia, Inc. and Blue Cross and Blue Shield Healthcare Plan of Georgia, Inc. are independent licensees of the Blue Cross and Blue Shield Association((R) ). The Blue Cross and Blue Shield names and symbols are registered marks of the Blue Cross and Blue Shield Association. Additional information about Blue Cross and Blue Shield of Georgia is available at www.bcbsga.com


'/>"/>
SOURCE Blue Cross and Blue Shield of Georgia; WellPoint, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Samplify Systems Announces Next Generation Signal-Compression Technology, Prism 3.0
2. Webcast Alert: Medial Saude S/A Announces Second Quarter 2009 Earnings Conference Call Webcast
3. NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract
4. Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
7. Webcast Alert: HCA Healthcare Announces HCA 2Q09 Earnings Report
8. Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
9. BBV Vietnam S.E.A. Acquisition Corp. Announces Signing of Letter of Intent for Business Combination with Migami, Inc.
10. JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc.
11. Duane Reade Holdings, Inc. Announces Pricing of Offering of 11.75% Senior Secured Notes Due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... expanded its executive staff with the addition of industry sales leader, Thomas (Tom) ... will develop the national distribution and sales network, direct the efforts of the ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
Breaking Medicine Technology: